Publications by authors named "Helena Bote"

Claim this Profile
R
Real-World Data of First-Line Cemiplimab Monotherapy for Metastatic Non-Small Cell Lung Cancer (NSCLC) with PD-L1 Expression ≥ 50%: A National Spanish Multicentric Cohort (CEMI-SPA Study).
Silvia Masini, Monica Antoñanzas Basa, Antonio Calles, Ruth Alvarez Cabellos, Ibone De Elejoste Echebarria, Helena Bote

Cancers (Basel)· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Spatially Preserved Multi-Region Transcriptomic Subtyping and Biomarkers of Chemoimmunotherapy Outcome in Extensive-Stage Small Cell Lung Cancer.
Melina Peressini, Rosario Garcia-Campelo, Bartomeu Massuti, Cristina Martí, Manuel Cobo, Helena Bote

Clin Cancer Res· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Brief report: High incidence of peridiagnosis thromboembolic events in patients with BRAF-mutant lung cancer.
Inmaculada Aparicio, Patricia Iranzo, Roxana Reyes, Helena Bote, María Saigi

Thromb Res· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Emerging immune checkpoint inhibitors for the treatment of non-small cell lung cancer.
Helena Bote, Andrés Mesas, Javier Baena, Mercedes Herrera, Luis Paz-Ares

Expert Opin Emerg Drugs· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis